These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 8792427)

  • 1. Age-dependent expression of P-glycoprotein gp170 in Caco-2 cell monolayers.
    Hosoya KI; Kim KJ; Lee VH
    Pharm Res; 1996 Jun; 13(6):885-90. PubMed ID: 8792427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
    Wu X; Whitfield LR; Stewart BH
    Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Existence of a p-glycoprotein drug efflux pump in cultured rabbit conjunctival epithelial cells.
    Saha P; Yang JJ; Lee VH
    Invest Ophthalmol Vis Sci; 1998 Jun; 39(7):1221-6. PubMed ID: 9620082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of P-glycoprotein function in human lymphocytes and Caco-2 cell monolayers by HIV-1 protease inhibitors.
    Profit L; Eagling VA; Back DJ
    AIDS; 1999 Sep; 13(13):1623-7. PubMed ID: 10509562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers.
    Imamura Y; Shimizu K; Yamashita F; Yamaoka K; Takakura Y; Hashida M
    Biol Pharm Bull; 2001 Aug; 24(8):930-4. PubMed ID: 11510488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a polarized efflux system in CACO-2 cells capable of modulating cyclosporin A transport.
    Augustijns PF; Bradshaw TP; Gan LS; Hendren RW; Thakker DR
    Biochem Biophys Res Commun; 1993 Dec; 197(2):360-5. PubMed ID: 7903526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of the coumarinic acid-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):787-93. PubMed ID: 12134948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers.
    Alsenz J; Steffen H; Alex R
    Pharm Res; 1998 Mar; 15(3):423-8. PubMed ID: 9563072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of P-glycoprotein-mediated secretion in absorptive drug permeability: An approach using passive membrane permeability and affinity to P-glycoprotein.
    Döppenschmitt S; Spahn-Langguth H; Regårdh CG; Langguth P
    J Pharm Sci; 1999 Oct; 88(10):1067-72. PubMed ID: 10514357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transport characteristics of tryptanthrin and its inhibitory effect on P-gp and MRP2 in Caco-2 cells.
    Zhu X; Zhang X; Ma G; Yan J; Wang H; Yang Q
    J Pharm Pharm Sci; 2011; 14(3):325-35. PubMed ID: 21824448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.
    Dahan A; Sabit H; Amidon GL
    AAPS J; 2009 Jun; 11(2):205-13. PubMed ID: 19319690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. P-glycoprotein-170 inhibition significantly reduces cortisol and ciclosporin efflux from human intestinal epithelial cells and T lymphocytes.
    Farrell RJ; Menconi MJ; Keates AC; Kelly CP
    Aliment Pharmacol Ther; 2002 May; 16(5):1021-31. PubMed ID: 11966513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclosporin A has low potency as a calcineurin inhibitor in cells expressing high levels of P-glycoprotein.
    Fakata KL; Elmquist WF; Swanson SA; Vorce RL; Prince C; Stemmer PM
    Life Sci; 1998; 62(26):2441-8. PubMed ID: 9651111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transport characteristics of fexofenadine in the Caco-2 cell model.
    Petri N; Tannergren C; Rungstad D; Lennernäs H
    Pharm Res; 2004 Aug; 21(8):1398-404. PubMed ID: 15359574
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential modulation of P-glycoprotein expression and activity by non-nucleoside HIV-1 reverse transcriptase inhibitors in cell culture.
    Störmer E; von Moltke LL; Perloff MD; Greenblatt DJ
    Pharm Res; 2002 Jul; 19(7):1038-45. PubMed ID: 12180537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolation and characterization of Caco-2 subclones expressing high levels of multidrug resistance protein efflux transporter.
    Horie K; Tang F; Borchardt RT
    Pharm Res; 2003 Feb; 20(2):161-8. PubMed ID: 12636153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cyclosporin A transport in cultured rabbit corneal epithelial cells: P-glycoprotein transport activity and binding to cyclophilin.
    Kawazu K; Yamada K; Nakamura M; Ota A
    Invest Ophthalmol Vis Sci; 1999 Jul; 40(8):1738-44. PubMed ID: 10393043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the efflux transporter(s) responsible for restricting intestinal mucosa permeation of an acyloxyalkoxy-based cyclic prodrug of the opioid peptide DADLE.
    Tang F; Borchardt RT
    Pharm Res; 2002 Jun; 19(6):780-6. PubMed ID: 12134947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of p-glycoprotein for the enteral absorption of cyclosporin A: in vitro-in vivo correlation.
    Fricker G; Drewe J; Huwyler J; Gutmann H; Beglinger C
    Br J Pharmacol; 1996 Aug; 118(7):1841-7. PubMed ID: 8842452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restricted transport of cyclosporin A across the blood-brain barrier by a multidrug transporter, P-glycoprotein.
    Tsuji A; Tamai I; Sakata A; Tenda Y; Terasaki T
    Biochem Pharmacol; 1993 Sep; 46(6):1096-9. PubMed ID: 8105783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.